Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Thats been a big issue
V., Sivadasan, S
Prior Authorization Support Dedicated Medicare Coverage Support Many Medicare patients feel overwhelmed by changing GLP-1 coverage rules, prior authorizations, pharmacy coordination, and eligibility questions
Weight Loss: In phase III trials, weight loss with the use of exenatide averaged between 0.9 and 2.8 kg over a 30-month time frame, with more weight loss associated when exenatide is added to existing metformin therapy
With GLP-1based therapies, lower calorie intake, poor protein intake, inactivity, and rapid weight reduction can all contribute to lean-mass loss
The fluorescence intensity was attained the maximum at 240 min (Figure S3)
)
